Il Nostro Team
Comunicazioni tecniche
Eventi
Fare News
Imprese Associate
{{ fifthTitle }}

FARE INSIEME - Ep. 100 - Eurosets, a jewel of resilience in the heart of the Emilian biomedical sector

«The mission is to introduce innovation into traditional solutions»

19/12/2022

.
 

In the heart of the Emilian biomedical district there is a company that has become a world reference for the production and marketing of advanced medical devices for extracorporeal circulation, cardiopulmonary support, heart surgery and orthopaedics. From Medolla to the rest of the world. Today Eurosets relies on almost 300 professionals, 5 branches and a turnover of almost 50 million euros. Giampaolo Colletti interviews Antonio Petralia (CEO of Eurosets), Giovanni Avanzini (Global Sales Director) and Mario Calzolari (Operations Director) for FARE INSIEME

of Giampaolo Colletti
@gpcolletti

Photocredit: Giacomo Maestri e Francesca Aufiero

Watchword: resilience. That is, the ability to cope positively with traumatic events and to reorganise one's life and work in the face of difficulties. Or even more. To reinvent oneself while remaining sensitive to the opportunities that the context presents, without ever alienating one's proper identity. After all, the word resilience is the best defining Eurosets, an excellence that was born in the early nineties in the heart of that Emilian biomedical district that the whole world envies us. The company is based in Medolla, a town of just over six thousand souls in the lower Po valley, a short distance from Modena. A land dedicated to work, sacrifice, to sharing, and to being and truly building a community. A land, however, affected by floods and earthquakes, which the community has always faced in a resilient way. Here is the word resilience again.

Story of an excellence
. But let's proceed in order and return to Eurosets. This company is specialised in the production and marketing of advanced medical devices for extracorporeal circulation, cardiopulmonary support, heart surgery and orthopaedics. «The mission is to introduce innovation into traditional solutions. All this means not only creating new products, but also having a different approach that brings Eurosets closer to healthcare personnel, becoming more receptive and able to respond to needs in a practical way», says Antonio Petralia, CEO of Eurosets. It all started in 1991: at the beginning the production line concentrated on the production of semi-finished components and devices, then in 1998 the acquisition by the Villa Maria Group took place, the second largest Italian private hospital group. This acquisition boosted growth: work thus began on some biomedical devices, such as those for chest drainage and post-operative auto transfusion systems. «Being part of a private hospital group allows us to be close to patients, to the healthcare personnel and to be updated on how surgical techniques change with time. This represents a distinctive feature for our positioning on the market and thanks to listening to healthcare personnel we are able to collect inputs and transmit them to our products, thus responding to sometimes latent needs», says Giovanni Avanzini, Global Sales Director of Eurosets. In 2012 the earthquake heavily damaged the headquarters. But we didn't give up and chose to build a new headquarters from scratch, which was inaugurated in 2016: over 31,000 square metres with very high safety standards. In record time, i.e. within a month of the earthquake, a new delocalised production started in Bastiglia, which allowed us to close the year without suffering losses, but quite the opposite, i.e. increasing our turnover compared to previous years. Then in 2014 we were affected by the flooding of the Secchia river, which flooded our warehouses and production offices. But again we started without stopping after only three weeks of refurbishing. Here comes the term resilience again. In 2015, three new offices opened in France, Germany and Belgium. In 2019 a new branch was established in China and again in 2020 the one in England. Today, 270 people work in the company, over 70% of women and with an average age of 44 years old. Eighty % of the 2021 turnover is generated abroad and in the last three years the growth has been double zero, with a forecast of 50 million euros for 2022.

Between research and development.
We have been able to design finished products and equipment thanks to the constant investments in research and development. Today 16 technicians work in R&D. They are engineers, biologists, university researchers. The assembly machines are also designed here. And then there is the quality sector with more strict regulations that need to be monitored constantly. Right, research. Over the years, investments have increased from 10% to 15% of turnover. We follow the patient in every area, from hospitalisation to returning home. And do it with intuitions put into a system thanks to a lot of innovation. So over the years Eurosets has filed over 45 international patents. «The vision is to help people get back to doing what they love the most, listening to the therapeutic needs of healthcare personnel and putting the patient at the centre of the company's production. By developing devices capable of responding to clinical situations in which the patient does not find benefit. The orientation is to introduce innovation in traditional therapeutic solutions. These are devices that can not only be used in hospitals but also adopted in contexts other than hospitals. This makes it possible to reach the patient wherever he/she is and to be increasingly close to the healthcare personnel», Petralia points out. But the difference is made by the territory. «It has allowed us to create and develop the professionalism necessary for this type of work. It is interesting to ask the question: why do even large biomedical multinationals maintain their production in the Biomedical Valley? Because this is where you find professionalism», says Mario Calzolari, Operations Director of Eurosets. The goal in the future is to introduce new devices on the market capable of responding to different therapeutic needs and to be the leaders in the interventional sector. «An example is Colibrì, the smallest and lightest life-saving device on the market. Thanks to its backpack specifically designed for transport, also suitable for travel by drone or by helicopter by way of its hoistable hook, it allows healthcare personnel to reach patients wherever they are», concludes Calzolari. So we try to design the future starting from the needs of healthcare professionals and of patients.

https://podcast.confindustriaemilia.it/

Read the other interviews

 

Altri Articoli di Fare news